(Q73645187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1 reference

N Meidenbauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D T Harris

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L E Spitler

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T L Whiteside

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

88-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Update on the diagnosis and treatment of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Follow-up evaluation of a phase II prostate cancer vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Cancer antigens: immune recognition of self and altered self

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Specific T cell recognition of peptides derived from prostate-specific antigen in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Molecular cloning of human prostate specific antigen cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Liposomes as carriers for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

The role of Fas/FasL in immunosuppression induced by human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

Cytotoxic T-lymphocytes against malaria and tuberculosis: from natural immunity to vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2820000501%2943%3A2%3C88%3A%3AAID-PROS3%3E3.0.CO%3B2-G

10.1002/(SICI)1097-0045(20000501)43:2<88::AID-PROS3>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10754524%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference